• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • Atopic Dermatitis Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: BulgariaChange country/region
Rhinology

Claus Bachert

MD, PhD

Former Chief of the Clinic and Professor | University Hospital of Ghent, Belgium

Claus Bachert

Biography

Claus Bachert, MD, PhD, received his medical training from the University of Heidelberg, Germany, and trained in ENT diseases and allergology in Mannheim and Düsseldorf. His research interests include the pathophysiology and management of diseases of the nose and sinuses, such as allergic and non-allergic rhinitis and chronic rhinosinusitis with and without nasal polyps. Specifically, he has worked on endotyping rhinosinusitis, developing innovative treatments, such as biologics for recalcitrant disease, and researching the role of Staphylococcus aureus in the inflammation of nasal polyp disease.  
 
Professor Bachert has published more than 700 peer-reviewed articles in international journals. He has received several national and international prizes and two honorary doctorate degrees (from Capital University in Beijing, China, and Democritus University in Thrace, Greece). He has been actively involved in the development of the Allergic Rhinitis and its Impact on Asthma international guidelines and the European Position Paper on Sinusitis and Nasal Polyposis, has served on the board of the European Academy of Allergy and Clinical Immunology and the World Allergy Organization, and has served as president and vice president of the German Allergy Society, as well as associate editor of the Journal of Allergy and Clinical Immunology.